Endocrinology

Top Story

Endogenous glucagon production less suppressed with OGTT vs. glucose infusion

August 23, 2016

Oral glucose tolerance testing results in less-suppressed endogenous glucagon production compared with isoglycemic intravenous glucose infusion in adults with and without diabetes, study data show.

Flip K. Knop, MD, PhD, of the Center for Diabetes Research, Gentofte Hospital, University of Copenhagen in Denmark, and colleagues evaluated 10 adults with type 2 diabetes (mean age, 57.1 years) and 10 matched controls (mean age, 56 years) without diabetes. Researchers sought to determine the differences in suppression of endogenous glucose production during OGTT and isoglycemic IV glucose infusion (IIGI).

In the Journals Plus

Reductions in fasting glucose, body weight delay progression of early type 2 diabetes

August 23, 2016
In adults with early type 2 diabetes, reductions in glucose level, driven by reductions in weight, can delay progression of the disease independent of any improvements…
In the Journals Plus

High-normal TSH levels tied to all-cause mortality

August 23, 2016
In adults with euthyroidism, the risk for all-cause mortality, cardiovascular mortality and cancer mortality was increased among those with high-normal…
In the Journals Plus

Hysterectomy may result in premature ovarian failure

August 23, 2016
Women who underwent hysterectomy with ovary preservation have lower levels of serum anti-Müllerian hormone, which may affect ovarian function, compared with women who…
In the Journals

Closed-loop insulin improves glucose control in pregnant women with type 1 diabetes

August 23, 2016
Pregnant women with type 1 diabetes achieved better glucose control with an overnight closed-loop intervention than with sensor-augmented pump therapy, according to data…
More News Headlines »
CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Video
Meeting News Coverage

VIDEO: Meeting MC recalls diabetes care over the decades

August 14, 2016
More »
Featured
ADA 2016

ADA 2016

CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
Current Issues
View the Current Issues